Are you a professional? Activate your profile

Are you already registered? Access Forgot your password?

Financial advisors
Calculation tools
- Calculates the risk and return of a securities portfolio
- Calculate your supplementary pension
News from the UK Stock Exchange

Funds / ETFs / Stock Ranking
Learn about finance
- Financial glossary
- Learning to invest
  The most important concepts of finance
Study Office
- Asset allocation
- Finance app ranking
About us

Tevogen Bio Holdings Inc. - news published 19 - readings 211

BACK

Tevogen Bio Holdings Inc.

Statement of Changes in Beneficial Ownership (Form 4)

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. UNITED STATES SECURITIES AND EXCHANGE COMMISSIO ...

15.03.2025

Tevogen Bio Holdings Inc.

Statement of Changes in Beneficial Ownership (Form 4)

12.03.2025

Tevogen Bio Holdings Inc.

Statement of Changes in Beneficial Ownership (Form 4)

07.03.2025

Tevogen Bio Holdings Inc.

Supplemental Prospectus (Form 424B3)

Filed Pursuant to Rule 424(b)(3) Registration No. 333-280414 PROSPECTUS SUPPLEMENT NO. 5 (To Prospectus dated August 5, 2024) Tevogen Bio Holdings Inc. This prospectus supplement updates and supplements the prospectus, dated August 5, 2024 (as supplemented to date, the "Prospectus"), which forms a part of our registration statement on Form S-1 (No. 333-280414). This ...

28.01.2025

Tevogen Bio Holdings Inc.

Tevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant Funding (Form 8-K)

Tevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant Funding ● The grant funding will further Tevogen Bio's mission to develop therapies for treatment of cancers and viral infections. ● Tevogen Bio may also utilize the grant funding to further expand its artificial intelligence effort. ● This grant is in addition to the previously announced $36 ...

28.01.2025

Tevogen Bio Holdings Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Ownership Submission FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. UNITED STATES SECURITIES A ...

26.12.2024

Tevogen Bio Holdings Inc.

Statement of Changes in Beneficial Ownership (Form 4)

26.12.2024

Tevogen Bio Holdings Inc.

Statement of Changes in Beneficial Ownership (Form 4)

26.12.2024

Tevogen Bio Holdings Inc.

Statement of Changes in Beneficial Ownership (Form 4)

26.12.2024

Tevogen Bio Holdings Inc.

Statement of Changes in Beneficial Ownership (Form 4)

26.12.2024

Tevogen Bio Holdings Inc.

Supplemental Prospectus - Form 424B3

Filed Pursuant to Rule 424(b)(3) Registration No. 333-280414 PROSPECTUS SUPPLEMENT NO. 4 (To Prospectus dated August 5, 2024) Tevogen Bio Holdings Inc. This prospectus supplement updates and supplements the prospectus, dated August 5, 2024 (as supplemented to date, the "Prospectus"), which forms a part of our registration statement on Form S-1 (No. 333-280414). This ...

19.11.2024

Tevogen Bio Holdings Inc.

Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________to_____ ...

19.11.2024

Tevogen Bio Holdings Inc.

Late Filing Notice Form NT 10 Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 001-41002 CUSIP Number: 88165K101 88165K119 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report ...

15.11.2024

Tevogen Bio Holdings Inc.

Statement of Changes in Beneficial Ownership - Form 4

Ownership Submission FORM 4 Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b). UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investmen ...

19.10.2024

Tevogen Bio Holdings Inc.

Supplemental Prospectus - Form 424B3

Filed Pursuant to Rule 424(b)(3) Registration No. 333-280414 PROSPECTUS SUPPLEMENT NO. 2 (To Prospectus dated August 5, 2024) Tevogen Bio Holdings Inc. This prospectus supplement updates and supplements the prospectus, dated August 5, 2024 (as supplemented to date, the "Prospectus"), which forms a part of our registration statement on Form S-1 (No. 333-280414). This ...

26.08.2024

Tevogen Bio Holdings Inc. - news published 19 - readings 211

Tevogen Bio Holdings Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Tevogen Bio Holdings Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Tevogen Bio Holdings Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Tevogen Bio Holdings Inc.

Supplemental Prospectus (Form 424B3)

Tevogen Bio Holdings Inc.

Tevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant Funding (Form 8-K)

Tevogen Bio Holdings Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Tevogen Bio Holdings Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Tevogen Bio Holdings Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Tevogen Bio Holdings Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Tevogen Bio Holdings Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Tevogen Bio Holdings Inc.

Supplemental Prospectus - Form 424B3

Tevogen Bio Holdings Inc.

Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)

Tevogen Bio Holdings Inc.

Late Filing Notice Form NT 10 Q

Tevogen Bio Holdings Inc.

Statement of Changes in Beneficial Ownership - Form 4

Tevogen Bio Holdings Inc.

Supplemental Prospectus - Form 424B3

You have reached the maximum number of requests. You can no longer send.

Become Member

€2,99per month

Become Member

€2,99per month

You have reached the maximum
number of requests.
You can no longer send.

Become
Member

Become
Member